PRA_Corporate_Overview_Fact_Sheet

C O R P O R AT E O V E R V I E W

E X P E R I E N C E

THE FUTURE OF CLINICAL DEVELOPMENT

PRA Health Sciences (PRA) provides innovative drug development solutions across all phases and therapeutic areas. But innovation just for the sake of innovation isn’t why we do it. Side-by-side with our clients, we strive to move drug discovery forward, to help them develop life-saving and life-improving drugs. We help change people’s lives for the better every day. It’s who we are. Innovating to help people is at the heart of our process, but it’s even more than that. It’s also our privilege.

PRA’s operational model encourages employees to initiate creative solutions to keep projects on track when they encounter the need. It’s this culture of flexibility and support that enables us to search for the right answer to any given problem, and to be able to utilize those answers in providing better solutions for our clients.

When a sponsor chooses you to help develop one of its promising compounds, it’s a compliment laden with great responsibility. At PRA, we understand and embrace that responsibility, having worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.

C O M P R E H E N S I V E P H A S E I - I V D R U G D E V E L O P M E N T

E X P E R T I S E

No. OF COUNTRIES WITHCOVERAGE

80+No. OF EMPLOYEES

10,000+No. OF CLINICAL STUDIES *

3,300+TECHNOLOGY EMPOWERS US TO CONNECT INSIGHTS AND MOVE IN ANY DIRECTION. ESPECIALLY FORWARD.

Cardio-Metabolic

7Diagnostics

23 3 3Genitourinary

Immunology

45InfectiousDiseases

Neurology &Psychiatry

Oncology &Hematology

12Respiratory

16Gastroenterology

2 Bioanalytical LaboratoriesUS and EU

8 Clinical Pharmacology Units3 in the US 5 in the EU

Clinical DevelopmentPhase II-III Studies

Strategic SolutionsStaff AugmentationFSP Embedded Solutions

Post-MarketingResearchTailored Approachto Real-world Research

6 Global Drug Safety Centers

“It isn’t enough to just be in multiple regions. Your project teams need to know how to harness this knowledge and to use it to make quality decisions that are aligned with the study goals.”

SEAN LEECH, Executive Vice President,Product Registration(Europe, Asia Pacific, and Africa)

*OVER THE PAST 5 YEARS

PRA OFFICESPRA COVERAGE

PRA Health Sciences conducts comprehensive phase I-IV biopharmaceutical drug development. To learn more about our solutions, please visit us at prahs.com or email us at [email protected] Health Sciences conducts comprehensive Phase I-IV biopharmaceutical drug development. To learn more about our solutions, please visit us at prahs.com or email us at [email protected].

The story of PRA Health Sciences would naturally talk about how we’ve become one of the world’s largest CROs. It would talk about our innovation and growth and would speak to our operational e�ciencies and transparency. It would highlight our expertise and customization. And it would touch on the incredible di�erences we’ve made, over our more than 30 years, in helping to bring to market everything from niche treatments and therapies to blockbuster drugs.

More than anything else, our story would be about people. Not only our over 10,000 employees operating in more than 80 countries, though they’d certainly be a big part of it, but also the people that inspire them. The heroes of any PRA Health Sciences story are the clients we serve and the people whose lives we help improve, all over the world. And our story has only just begun.